[[Letterhead of The9 Limited] October 25, 2010 VIA EDGAR AND FACSIMILE Ms. Kathleen Collins, Accounting Branch Chief Re: The9 Limited (the Company) Dear Ms. Collins and Ms. Kindelan, Risk Factors 1. The Company respectfully advises the Staff that the pledge of the equity interests held by Jun Zhu and Yong Wang in Shanghai IT has not been registered with relevant]
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
[[Letterhead of The9 Limited] October 25, 2010 VIA EDGAR AND FACSIMILE Ms. Kathleen Collins, Accounting Branch Chief Re: The9 Limited (the Company) Dear Ms. Collins and Ms. Kindelan, Risk Factors 1. The Company respectfully advises the Staff that the pledge of the equity interests held by Jun Zhu and Yong Wang in Shanghai IT has not been registered with relevant]
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
[JOINT FILING AGREEMENT Joint Filing Agreement CAFOONG LIMITED CHENG CHUNG HING, RICKY CHENG TAI PO] [SCHEDULE 13D AMENDMENT NO. 4 SECURITIES & EXCHANGE COMMISSION SCHEDULE 13D (Amendment No. 4)* China Rural-Metro Holdings Ltd (Name of Issuer) Ordinary shares, par value US$0.001 per share (Title of Class of Securities) G3163G 10 4 (CUSIP Number) Cafoong Limited Cheng Chung Hing, Ricky Cheng Tai Po c/o Man Sang International (B.V.I.) Limited Suite 2208, 22/F Sun Life Tower, The]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica,ns-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica,ns-serif} .FormTitle {font-size: medium; font-family: arial, helvetica,ns-serif; font-weight: bold} .FormName {font-size: large; font-family: arial,]
[JOINT FILING AGREEMENT Joint Filing Agreement CAFOONG LIMITED CHENG CHUNG HING, RICKY CHENG TAI PO] [SCHEDULE 13D AMENDMENT NO. 4 SECURITIES & EXCHANGE COMMISSION SCHEDULE 13D (Amendment No. 4)* China Rural-Metro Holdings Ltd (Name of Issuer) Ordinary shares, par value US$0.001 per share (Title of Class of Securities) G3163G 10 4 (CUSIP Number) Cafoong Limited Cheng Chung Hing, Ricky Cheng Tai Po c/o Man Sang International (B.V.I.) Limited Suite 2208, 22/F Sun Life Tower, The]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica,ns-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica,ns-serif} .FormTitle {font-size: medium; font-family: arial, helvetica,ns-serif; font-weight: bold} .FormName {font-size: large; font-family: arial,]
[EXCEED COMPANY LTD. TO ATTEND THE GOLDMAN SACHS CHINA INVESTMENT FRONTIER CONFERENCE Fujian, China For further information, including presentations for download, please visit the Company’s website: http://www.ir.xdlong.cn . About Exceed Company Ltd. Exceed Company Ltd. designs, develops and engages in wholesale of footwear, apparel and accessories under its own brand, XIDELONG, in China. Since it began operations in 2002, Exceed] [FORM 6-K ______________________ Commission File No. 001-33799 ______________________ EXCEED COMPANY LTD. ______________________ Suite 8, 20/F, One International Finance Centre 1 Harbour View Street, Central, Hong Kong. T: +852 3669 8105 ______________________ x ¨ Form 20-F ¨ x Yes 82- Exceed Company Ltd.]
[Biostar Pharmaceuticals, Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500 XIANYANG, China, Oct 25/PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, (Nasdaq:BSPM - News) ("Biostar" or "thempany"), a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acidpsules ("Xin Aoxingpsules"), and a variety of pharmaceutical products, today]
